
Nuvalent to Present at the 44th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Dec. 22, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven…








